Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Knightscope Files Prospectus Supplement to Expand ATM Offering

Knightscope, Inc. filed a Form 8-K with the SEC on September 21, 2026, disclosing the filing of a prospectus supplement to increase the maximum number of shares issuable under its existing at-the-market offering agreement with H.C. Wainwright & Co., LLC.

Shwetambri Chauhan | 21 September 2026

QuickLogic CFO Resigns; James Sullivan Named Replacement

QuickLogic Corporation filed a Form 8-K on September 21, 2026, disclosing the resignation of Chief Financial Officer Elias Nader effective September 18, 2026, and the appointment of James Sullivan as incoming CFO effective October 5, 2026.

Shwetambri Chauhan | 21 September 2026

Athene Holding Releases Asset Risk Presentation for Investors

Athene Holding Ltd. filed a Form 8-K on September 21, 2026, disclosing that it made available to investors a presentation titled "Athene Asset Risk & Stress Considerations, September 2026 Update" on its investor relations website.

Vinay Lochav | 21 September 2026

StoneBridge Acquisition II Files PFIC Annual Statement for 2025

StoneBridge Acquisition II Corporation filed a Form 8-K with the SEC on September 21, 2026, reporting that it made available its Passive Foreign Investment Company Annual Information Statement for the taxable year ended December 31, 2025.

Vinay Lochav | 21 September 2026

Cue Biopharma Reports Positive Phase 2 Data for CUE-221 in Chronic Urticaria

Cue Biopharma, Inc. filed a Form 8-K with the SEC on September 21, 2026, disclosing positive topline results from a Phase 2 clinical trial of CUE-221 in Chronic Spontaneous Urticaria conducted in China by Genesis Life Sciences, an affiliate of Ascendant Health Ltd.

Manish Choudhary | 21 September 2026

Inflection Point VII Files 8-K on Elroy Air Merger

Inflection Point Acquisition Corp. VII filed a Form 8-K on September 21, 2026 under Item 7.01 Regulation FD Disclosure, furnishing an investor presentation prepared in connection with its proposed business combination with Elroy Air, Inc., a Delaware corporation, coinciding with an analyst day held …

Manish Choudhary | 21 September 2026

This Nasdaq Biotech's Fate Rests on a Single Set of Cancer Trial Results

Cancer trial results matter for Actuate Therapeutics (NASDAQ:ACTU) because a single drug's performance against one of the deadliest cancers is essentially the whole company. Actuate is a clinical-stage biotechnology firm developing elraglusib, a drug that inhibits a protein called GSK-3-beta, as a treatment for …

Nitish Kishor | 21 September 2026

Acme United (NYSE American:ACU) Stock: Scissors, Rulers, and Steady Everyday Demand

Everyday product demand is the foundation of Acme United (NYSE American:ACU), and comparing it with the broad market of smaller companies on that basis is instructive because its products are so ordinary and so repeatable. Acme United makes and sells cutting tools, scissors, shears, …

Nitish Kishor | 21 September 2026

National CineMedia Acquires Captivate, Enters $300M Credit Deal

National CineMedia, Inc. filed an 8-K on September 21, 2026, reporting that its wholly-owned subsidiary NCM Holdings, LLC completed the acquisition of Captivate Holdings, LLC and Captivate Network Holdings, Inc. on September 18, 2026, and simultaneously entered into a new $300 million credit facility …

Anjali Anand | 21 September 2026

Ocean Capital Acquisition Sponsor Ownership Transfer

Ocean Capital Acquisition Corporation filed a Form 8-K on September 21, 2026, disclosing that on September 17, 2026, all issued and outstanding equity interests in its sponsor, SB Capital Holding Corporation, were transferred to Chi-Ping Cindy Lee.

Aditi Sarkar | 21 September 2026
Support

Hi! How can we help you today?

Loading…